Evaluation of concordance among physicians on medical emergency priorities using fleiss kappa coefficient

Authors

  • Icler Sisalema Aguilar
  • Marcia Alexandra Silva Mata
  • Miguel Ramos Argilagos

Keywords:

COVID-19, Fleiss Kappa, Manchester Triage System, concordance, medical emergencies

Abstract

Introduction: The Fleiss Kappa coefficient is used to assess inter-rater concordance, posing challenges in medical practice.

Objective: The objective of the study was to assess inter-physician agreement on emergency medical priorities using the Fleiss Kappa coefficient in a hospital in Ecuador, during the COVID-19 pandemic.

Methods: Inter-rater concordance was determined using the Fleiss Kappa statistic. The study was observational, cross-sectional, and prospective. Pre-established criteria for assessing inter-observer concordance were followed. The study population consisted of eight physicians belonging to the staff of the Intensive Care Unit (ICU) of a hospital of Ecuador.

Results: An overall Kappa value of 0.606 with an asymptotic standard error of 0.034, a Z-value of 17.816, and a P-value of 0.000 were obtained. The 95 % asymptotic confidence intervals indicated that the Kappa value ranged from 0.539 to 0.673, which suggested that the overall agreement was in the moderate-considerable range. The results of the Kappa coefficients for individual categories indicated a high level of concordance in most categories, except Category 5, where a significant lack of concordance among physicians was observed.

Conclusions: There was significant agreement among physicians in their ratings. These findings provided valuable information to improve consistency in classifying patients in emergency situations during the COVID-19 pandemic.

Downloads

Download data is not yet available.

Published

2023-10-16

How to Cite

1.
Sisalema Aguilar I, Silva Mata MA, Ramos Argilagos M. Evaluation of concordance among physicians on medical emergency priorities using fleiss kappa coefficient. Rev Cubana Inv Bioméd [Internet]. 2023 Oct. 16 [cited 2025 Aug. 2];42(2). Available from: https://revibiomedica.sld.cu/index.php/ibi/article/view/3029